Jagsonpal Pharmaceuticals Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 605.97 million compared to INR 540.55 million a year ago. Revenue was INR 609.1 million compared to INR 548.77 million a year ago. Net income was INR 3.69 million compared to INR 68.48 million a year ago. Basic earnings per share from continuing operations was INR 0.14 compared to INR 2.61 a year ago. Diluted earnings per share from continuing operations was INR 0.14 compared to INR 2.61 a year ago.